#China #Shenzhen #diabetes management #digital therapy #AGP Summit

Innovations in Diabetes Management

In May 2026, Shenzhen hosted the 4th AGP & DTx Summit, focusing on advancements in diabetes care under the theme "Beyond Glucose." This event drew international experts, healthcare professionals, researchers, and patient representatives to discuss how continuous glucose monitoring (CGM) data could go beyond simple oversight to provide substantial clinical value.

Key Takeaways from the Summit

One prevailing message throughout the summit was the understanding that CGM should not only be viewed as a monitoring tool. Its greater potential lies in transforming glucose data into clinical insights, treatment decisions, and impactful behavioral changes.

Professor Andrej Janež from the International Consortium for AGP DTx Research revealed that over the past two years, their research foundation has supported 20 investigator-initiated studies across 14 countries focusing on CGM and continuous ketone monitoring (CKM). These studies emphasize various key aspects, including accuracy in specific populations, dietary patterns, glycemic responses, AI-supported platforms, and clinical monitoring applications.

The Role of Digital Therapies

Professor Sofianos Andrikopoulos underscored the value of digital therapies (DTx) in integrating software interventions, lifestyle recommendations, medication support, and comprehensive care models. Notably, data presented during the summit indicated that patients utilizing digital therapies experienced an average decrease in HbA1c by 0.54 percentage points, reinforcing the role of structured interventions in diabetes management.

Metabolic Phenotyping and Personalized Care

In his presentation, Professor Wei Qiang discussed utilizing combinations of hospitalization metrics alongside CGM and AGP data to identify metabolic phenotypes and treatment responses in hospitalized Type 2 diabetes patients. This potential for targeted, personalized care is a significant advancement in diabetes management.

The Importance of CGM and AI Integration

Professor Shannon Lin highlighted that CGM could reach a plateau regarding effectiveness, thus pointing to the importance of data-driven management strategies. There is significant interest from clinicians and patients alike when it comes to integrating CGM with AI for predictive analytics and tailored recommendations. Professor Xiao Luo shared her findings that CGM combined with CKM could accurately reflect changes in glucose and ketone levels during fasting and feeding cycles, making metabolic interventions more effective.

Tom Vesely, a representative for patients living with Type 1 diabetes for nearly 40 years, reminded attendees that while CGM technology makes daily glucose fluctuations visible, the goal is to ensure not just time in range but increased quality of life.

Together, the discussions and findings from the AGP & DTx Summit signify a transformative shift in diabetes treatment — moving from mere monitoring to effectuating significant lifestyle changes. This evolution highlights the pivotal role of digital innovations in healthcare, offering hope for more effective management of diabetes and improved patient outcomes.